1 in 10 Filipinos suffer infertility - study

MANILA, Philippines - One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

The study showed that while majority of couples with fertility problems seek initial consultation, treatment is hindered by patients’ perception of the high cost of treatment and lack of understanding on the procedures involved.


Merck Serono is the biopharmaceutical division of Merck KGaA with headquarters in Darmstadt, Germany.

The company released the result of the study as it embarks on a campaign to raise awareness on infertility in the Philippines and its treatment.

The campaign dubbed "Hope for Starting Families", aims to provide couples with relevant information on infertility treatment through public information efforts such as a series of lay fora across major cities nationwide, and a dedicated website on infertility such as www.fertilityphilippines.com. The website will serve as a repository of information on the causes of infertility, available treatment options as well as a directory of medical experts and treatment centers in the Philippines.

Merck said one of the barriers for treatment also stems from the misconception that treatment is not available locally, or that it is more effective in other countries.


Under its campaign, Merck informs Filipino couples that fertility treatments are available from five assisted reproductive technology (ART) centers in the Philippines and that their success rates are comparable to international standards.

According to the Philippine Society of Reproductive Endocrinology and Infertility (PSREI), Filipino couples are encouraged to seek help from fertility experts – and to do so urgently - if they truly want to realize their dream of starting a family.

"Fertility treatments are being successfully done in the country for many years now, and I am happy to report that we have helped many couples conceive with an average success rate of 30 to 50 percent," said Tim Kneen, Regional Vice President of Merck Serono in Asia Pacific.

The Hope for Starting Families campaign is aligned with Merck’s efforts across Asia, following a recent study commissioned by Merck Serono that has been endorsed by the Asia Pacific Initiative on Reproduction (ASPIRE).

Called Starting Families Asia, the study is the largest study of its kind, with 1,000 women across 10 Asian countries surveyed. The study revealed critical knowledge gaps about fertility, the key causes of infertility and fertility treatment options.

The Starting Families Asia reported less than half of the women surveyed across the region understand that a couple is classified as infertile if they fail to conceive after one year of trying (43 percent); that a woman in her forties has a lower chance of falling pregnant than a woman in her thirties (36 percent); and that a healthy lifestyle does not necessarily guarantee fertility (32 percent).

The findings could mean that many women are not seeking the help or treatment that could improve their chances of conceiving – particularly for women above age 35.

"Asian countries have among the lowest fertility rates in the world and the declining birth rates are a cause for concern. Merck Serono commissioned the Starting Families Asia study to better understand Asian women’s decision-making considerations around having a baby. It is our hope that insights from this study, which highlights critical fertility knowledge gaps that need to be addressed, will assist healthcare professionals and policy makers in addressing this acute challenge," Kneen said.

Kneen added Merck will to continue to work closely with doctors, ART centers and patients who have successfully given birth to babies through assisted reproductive techniques to produce and share updated content on significant fertility issues.  Merck will also conduct workshops on Basic Infertility Management for obstetricians and gynecologists.

source: philstar.com

Trend in genital cosmetic surgery alarms US gynecologists

LOS ANGELES -- Trained as a gynecologist and reconstructive surgeon, Dr. John Miklos calls himself a "medical tailor," specializing in surgery to reshape a woman's private parts.

The Atlanta surgeon, who has performed gynecological surgery for nearly 20 years, cites cases of patients who say their sexual response improved after vaginoplasty, a procedure to surgically tighten a vagina stretched by childbirth or aging.

"Women come to me and say they don't have the urge to have sex anymore because they don't feel anything," Miklos said. "I guarantee that if a man didn't feel anything, he wouldn't have sex either."

Female genital cosmetic surgery is a small segment of the US plastic surgery market, but it is growing, with thousands of women estimated to undergo such procedures every year. That growth comes despite a warning from the American College of Obstetricians and Gynecologists in a 2007 notice to member physicians that strongly questioned the medical validity and safety of female genital cosmetic surgery. Earlier this year the group debated the trend at its annual meeting in San Diego.

"None of these procedures have proven effectiveness, and there is potential for harm," Dr. Cheryl Iglesia, a Washington, D.C., gynecologist and former ACOG committee member, wrote in an editorial published in the June issue of Obstetrics and Gynecology. "Women are being misled or are confused about what is normal," she wrote -- and about what constitutes a condition that can actually be helped through treatment.

Critics say the trend is the latest service aimed at women pursuing an impossible ideal of physical perfection, hyped by Internet pornography and advertising by surgeons who may not explain all the risks, such as infections, scarring, pain and the loss of the very sensations some patients seek to enhance.

"Even when women are told of potential complications, like insensitivity of the clitoris ... they still may be unstoppable if they have the notion that they need a younger-looking or more perfect or more desirable vulva," said Harriet Lerner, a psychologist specializing in women's issues.

More than 2,140 U.S. women underwent "vaginal rejuvenation" last year, according to the American Society for Aesthetic Plastic Surgery. The International Society of Aesthetic Plastic Surgeons put the U.S. total at nearly 5,200 in 2010. Experts note such figures do not include the many procedures done by gynecologists.

ACOG not only points to the risks of genital surgery but also emphasizes that female sexual response is driven by psychological factors rather than genital appearance. The group has asked its members to be aware of how they might unwittingly influence a patient to consider surgery.

In practices across the country, doctors say more women, from teenagers to those in their late 70s, want to discuss the procedures, which can cost between $2,500 and $12,000 and are usually not covered by insurance.

"I tell every patient you are normal the way you are," said Miklos, who each year performs as many as 180 labiaplasties to cut back the skin flaps surrounding the vaginal opening. "I would never suggest that they get one. What is the right size of a nose, or a chin? That's up to the individual. It's her right to decide."

From repair to aesthetics

Corrective gynecological surgery has been available for decades, including procedures to alleviate incontinence or sagging of the vaginal canal after childbirth. In the 1990s surgeons began offering procedures that promised the improved aesthetics, self-esteem and confidence associated with nose jobs or other plastic surgeries.

"One side was longer than the other side. ... It was something that bothered me," said Kari, a 36-year-old labiaplasty patient of Beverly Hills, California, plastic surgeon Fardad Forouzanpour. (She did not want to give her last name.) "It makes me more comfortable. I like the way that it looks."

She said her boyfriend was not involved in her decision, but she did "look at a few Playboys here and there."

One patient, who did not want to use her name, said she had surgery because she hated the look of her labia, even though her husband had no problem with her appearance.

Other procedures include creating a new hymen for "revirgination" and "G-spot amplification," which involves injecting the area in the front wall of the vagina with collagen or another filler to enhance sexual gratification. In some cases, patients may not leave satisfied. One way Miklos seeks clients is by running a website called botchedlabia.com, where women who have already experienced complications can get advice on revisions.

Undue influence

Surgeons say many patients have been influenced by images of the waxed, buffed or surgically altered genitals of porn actresses.

"They see these porn stars who have things done, and they look so nice and clean-cut," said Forouzanpour, who does 15 to 25 labiaplasties a month. "It is normal to have some extra skin, or some discoloration."

While studies have shown some social advantages to plastic surgery that improves a person's overall appearance in public, like a nose job or face-lift, there is no data showing the benefits of altering one's genitals.

"The ethical question is: How much are you playing on women's insecurities?" Dr. Iglesia said. "Women are getting very much duped into thinking there is a standard look for the vulva."

By all measures, Miklos has thrived on his expertise. Along with partner Dr. Robert Moore, he now has practices in Atlanta, Georgia and Beverly Hills. He says he tries to stay away from procedures with more dubious outcomes.

For example, surgery claiming to enhance the "G-spot," which may play a role in sexual arousal, raises red flags as no controlled studies have been done, or are likely to be done, to show whether it has any effect.

"I don't routinely do them. People ask for them, but I don't want someone to pay $1,000 and have high hopes," Miklos said. "People get upset when there is no response."

source: interaksyon.com